Shelly Maman

848 citations
12 papers · 649 indexed · 1 hit paper · h-index 9
Topics
Neuroblastoma Research and Treatments (8 papers)Cancer, Hypoxia, and Metabolism (6 papers)Lung Cancer Research Studies (3 papers)

In The Last Decade

Shelly Maman

12 papers receiving 644 citations

Hit Papers

A history of exploring cancer in context20182026202020232018100200300

Peers

Shelly Maman
Comparison fields: 5 of 73
  • Molecular Biology 263
  • Oncology 241
  • Cancer Research 216
  • Immunology 154
  • Biomedical Engineering 123
Replace Shan M. Chin with:
Shan M. Chin United States
Lifeng Tian United States
Chi-Ping Day United States
Diana Behrens Germany
Martin Nurmik Luxembourg
Yuze Hua China
Denisa Dragu Romania
Jingshu Meng China
Shihe Hou United States
James R. Whittle Australia
Shelly Maman relative to Shan M. Chin United States Shan M. Chin's profile →
Citations per field
00.5×1.5×
Shan M. Chin · 1×
Citations per year

Countries citing papers authored by Shelly Maman

Since Specialization
Citations

This map shows the geographic impact of Shelly Maman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelly Maman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelly Maman more than expected).

Fields of papers citing papers by Shelly Maman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelly Maman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelly Maman. The network helps show where Shelly Maman may publish in the future.

Co-authorship network of co-authors of Shelly Maman

This figure shows the co-authorship network connecting the top 25 collaborators of Shelly Maman. A scholar is included among the top collaborators of Shelly Maman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelly Maman. Shelly Maman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 2
2
A history of exploring cancer in contextbreakdown →
378
3 38
4 36
5 61
6 7
7 6
8 50
9 19
10 15
11 15
12 22

About Shelly Maman

Shelly Maman is a scholar working on Neurology, Cancer Research and Oncology, having authored 12 papers that have together received 649 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Cancer Research (216 citations), Oncology (241 citations) and Immunology (154 citations). Shelly Maman has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Isaac P. Witz, Orit Sagi‐Assif, Tsipi Meshel, Ilana Yron, Weirong Yuan, Wuyuan Lu, N. Kariv, Metsada Pasmanik‐Chor, Weiyue Lu and Yona Keisari. Their work appears in journals such as Nature reviews. Cancer, Nature Reviews Drug Discovery and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026